title: Oral and maxillofacial pathology case of the month. Palatal melanosis associated with imatinib mesylate therapy.
authors.affiliation: Department of Diagnostic and Biomedical Sciences, The University of Texas School of Dentistry at Houston, USA.
authors.forename: Yau-Hua
authors.initials: YH
authors.lastname: Yu
authors.forename: Yusuf
authors.initials: Y
authors.lastname: Shere
authors.forename: Nadarajah
authors.initials: N
authors.lastname: Vigneswaran
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D003937:Diagnosis, Differential; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000201:enzymology; D008297:Male; D008548:Melanosis / Q000139:chemically induced*; D009061:Mouth Mucosa / Q000187:drug effects; D021362:Palate, Hard; D010879:Piperazines / Q000009:adverse effects*; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases